Intracranial Stenosis Stents Market To Reach $1.1 Billion By 2030

Intracranial Stenosis Stents Market Growth & Trends

The global intracranial stenosis stents market size is expected to reach USD 1.1 billion by 2030 and is expected to expand at 4.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Stroke is a leading cause of death and morbidity in the U.S. as well as globally. Large artery atherosclerosis is responsible for approximately 20% of all ischemic strokes, with nearly 50% of them being intracranial, and the condition has a comparatively high recurrence rate, regardless of medical treatment.

Furthermore, nearly 10% of ischemic strokes in the U.S. and up to 50% in Asia are caused by intracranial stenosis. The actual incidence of Intracranial Atherosclerotic Disease (ICAD) might be greater because symptomatic, non-stenosing atherosclerotic plaques may go undiagnosed with the current diagnostic methods. As per a study report, an autopsy analysis of stroke patients showed a significant number of intracranial non-stenosing atherosclerotic plaques, approximately 6% of which had superimposed thrombi and were presumed to be accidental results of an ischemic event.

Moreover, compared to Americans, Hispanics, Africans & Asians have higher rates of ICAD. The disparity in ICAD prevalence by race and ethnicity is probably caused by variations in risk factor profiles, dietary habits, and genetic predispositions. For instance, a study attributed the higher prevalence of hypertension, hyperlipidemia, and diabetes mellitus in African American patients to the high prevalence of ICAD.

A few major advantages of minimally invasive procedures include:

• These procedures cause less discomfort and postoperative pain

• Unlike conventional surgeries that make use of large openings, minimally invasive procedures rely on small openings

• Minimally invasive procedures result in a shorter hospital stay

• These procedures result in fewer scars

As per a research study on 169 patients, published in the Radiological Society of North America, 20 individuals (11.8%) faced complications. 10.5% of the individuals had a stroke (4 patients had symptomatic intracranial hemorrhages [ICHs]; 6 patients had an ischemic stroke) and two of these patients died. Two patients had asymptomatic ICHs and one had a transient ischemic attack, while the other had an asymptomatic dissection.

In Europe, there have been concerns about the shortage of skilled professionals in interventional neuroradiology. For instance, a study published in the European Journal of Neurology in 2018 found that there is a need for more training programs and resources to support the development of expertise in this area. The study also found that the shortage of skilled professionals can limit access to specialized treatments, such as intracranial stenosis stenting, for patients with neurological disorders.

 Request a free sample copy or view report summary: Intracranial Stenosis Stents Market Report

Intracranial Stenosis Stents Market Report Highlights

• Self-expanding stents dominated the overall market with 34.9% of the revenue share in 2022. Intracranial stenosis self-expanding stents are designed to open the narrowed areas and improve the blood flow in the brain. These stents have proven to be an effective treatment option as they have a high success rate with a low complication rate

• The hospital segment held the largest market share of 80.8% in 2022. Intracranial stenosis procedures are complicated and critical surgeries, which depend on high-quality durable equipment available in hospitals. However, increasing preference for minimally invasive endovascular procedures in hospitals has led to the rising adoption of intracranial stents for stenosis patients

• Ambulatory surgical centers are anticipated to showcase the fastest growth rate over the forecast period. These facilities offer patients with shorter hospital stays, quality hospitalization in stroke units, and lower readmission rates

• The growth of the market in North America can be attributed to the presence of advanced healthcare facilities in the region, an increasing preference for minimally invasive procedures, the rising prevalence of atherosclerosis & brain strokes, the growing geriatric population, and the presence of key industry players

Intracranial Stenosis Stents Market Segmentation

Grand View Research has segmented the global intracranial stenosis stents market based on product, end-use, and region: 

Intracranial Stenosis Stents Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Self-expanding Stents

• Embolization Coil Support Intracranial Stents

• Venous Sinus Stents

• Balloon-expanding & Other Stents

Intracranial Stenosis Stents End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Others

Intracranial Stenosis Stents Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

  • UK

  • Germany

  • France

  • Spain

  • Italy

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Intracranial Stenosis Stents Market

• phenox GmbH

• Medtronic

• Acandis GmbH

• MicroPort Scientific Corporation

• MicroVention, Inc.

• CERENOVUS (Johnson & Johnson)

• Sino Medical Sciences Technology, Inc.

• Stryker

• Balt